Skip to main content
RNAC
NASDAQ Life Sciences

Cartesian Therapeutics Secures Up to $150M Senior Term Loan, Bolstering Cash Runway

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$7.237
Mkt Cap
$198.325M
52W Low
$5.6
52W High
$15.57
52W Position info
29% above low
Off High info
54% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

RNAC sits 29% above its 52-week low of $5.6.

Summary

Cartesian Therapeutics secured a senior secured term loan facility of up to $150 million, led by K2 HealthVentures. An initial $50 million is immediately available, with additional tranches tied to milestones and lender discretion. This significant financing follows recent reports of substantial net losses ($39.2M in Q1 2026) and sharply declining revenue, which had raised concerns about the company's cash runway. The up to $150 million facility substantially extends the company's operational runway and supports its clinical development, mitigating immediate liquidity risks. While primarily non-dilutive, the agreement includes lender conversion rights for up to $15 million of principal at $8.2526 per share, which is a premium to the current stock price.

At the time of this announcement, RNAC was trading at $7.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $198.3M. The 52-week trading range was $5.60 to $15.57. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

RNAC - Latest Insights

RNAC
Nov 05, 2026, 9:32 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $6.86
Real-time Price: $6.11 info
Change: -$0.745 (-11%) info
Market Cap: $186.983M info
RNAC
Sep 29, 2026, 7:31 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.24
Real-time Price: $6.11 info
Change: -$1.13 (-16%) info
Market Cap: $186.983M info
RNAC
Aug 06, 2026, 7:05 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.26
Real-time Price: $6.11 info
Change: -$2.15 (-26%) info
Market Cap: $186.983M info
RNAC
Aug 06, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.26
Real-time Price: $6.11 info
Change: -$2.15 (-26%) info
Market Cap: $186.983M info
RNAC
Jun 09, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.40
Real-time Price: $6.11 info
Change: -$0.290 (-5%) info
Market Cap: $186.983M info